Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

49.41
-0.2600-0.52%
Pre-market: 49.22-0.1900-0.38%08:58 EDT
Volume:1.95M
Turnover:96.57M
Market Cap:120.38B
PE:18.13
High:50.18
Open:50.02
Low:49.33
Close:49.67
Loading ...

Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

GlobeNewswire
·
20 Mar

Sanofi starts annual production of vaccines for 2025-26 flu season

TIPRANKS
·
15 Mar

Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

PR Newswire
·
15 Mar

AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies

Zacks
·
10 Mar

Regeneron, Sanofi presents results from ADEPT Phase 2/3 trial on Dupixent

TIPRANKS
·
10 Mar

Why Is Regeneron (REGN) Down 4.1% Since Last Earnings Report?

Zacks
·
07 Mar

Berenberg Lifts Price Target on Sanofi to EUR120 From EUR115, Keeps Buy Rating

MT Newswires Live
·
05 Mar

Euroapi SA (EAPIF) (FY 2024) Earnings Call Highlights: Navigating Challenges and Embracing ...

GuruFocus.com
·
05 Mar

Berenberg Bank Reaffirms Their Buy Rating on Sanofi (SNY)

TIPRANKS
·
05 Mar

Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial

Benzinga
·
04 Mar

Is Sanofi (SNY) The Best Immunology Stock To Buy Now?

Insider Monkey
·
02 Mar

Cytokinetics Q4 Loss Wider Than Expected, Aficamten in Focus

Zacks
·
01 Mar

Kymera's Q4 Loss Wider Than Expected, Pipeline in Focus

Zacks
·
01 Mar

Q4 2024 Cytokinetics Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Mar

Kymera Therapeutics Inc (KYMR) Q4 2024 Earnings Call Highlights: Strategic Collaborations and ...

GuruFocus.com
·
28 Feb

Novavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...

GuruFocus.com
·
28 Feb

Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds

Blockhead
·
28 Feb

Q4 2024 Vir Biotechnology Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value

Benzinga
·
28 Feb

Novavax reports large quarterly revenue declines, rethinks its strategic direction

Yahoo Finance
·
27 Feb